Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:administration of heavy metal antagonist'
(id=7014039 ; fe=en:administration of heavy metal antagonist ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6700 creation date=2017-06-25 touchdate=2025-11-03 03:26:01.000)
≈ 194 relations sortantes

  1. en:administration of heavy metal antagonist -- r_associated #0: 188 / 1 -> médecine
    n1=en:administration of heavy metal antagonist | n2=médecine | rel=r_associated | relid=0 | w=188
  2. en:administration of heavy metal antagonist -- r_associated #0: 125 / 0.665 -> procédure médicale
    n1=en:administration of heavy metal antagonist | n2=procédure médicale | rel=r_associated | relid=0 | w=125
  3. en:administration of heavy metal antagonist -- r_associated #0: 110 / 0.585 -> injection de l'antagoniste d'un métal lourd
    n1=en:administration of heavy metal antagonist | n2=injection de l'antagoniste d'un métal lourd | rel=r_associated | relid=0 | w=110
  4. en:administration of heavy metal antagonist -- r_associated #0: 105 / 0.559 -> perfusion de l'antagoniste d'un métal lourd
    n1=en:administration of heavy metal antagonist | n2=perfusion de l'antagoniste d'un métal lourd | rel=r_associated | relid=0 | w=105
  5. en:administration of heavy metal antagonist -- r_associated #0: 80 / 0.426 -> administration de l'antagoniste d'un métal lourd
    n1=en:administration of heavy metal antagonist | n2=administration de l'antagoniste d'un métal lourd | rel=r_associated | relid=0 | w=80
  6. en:administration of heavy metal antagonist -- r_associated #0: 79 / 0.42 -> en:administration of anticoagulant
    n1=en:administration of heavy metal antagonist | n2=en:administration of anticoagulant | rel=r_associated | relid=0 | w=79
  7. en:administration of heavy metal antagonist -- r_associated #0: 79 / 0.42 -> en:administration of antipyretic
    n1=en:administration of heavy metal antagonist | n2=en:administration of antipyretic | rel=r_associated | relid=0 | w=79
  8. en:administration of heavy metal antagonist -- r_associated #0: 78 / 0.415 -> en:administration of drug or medicament via intrapleural route
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via intrapleural route | rel=r_associated | relid=0 | w=78
  9. en:administration of heavy metal antagonist -- r_associated #0: 78 / 0.415 -> en:administration of hormone (procedure)
    n1=en:administration of heavy metal antagonist | n2=en:administration of hormone (procedure) | rel=r_associated | relid=0 | w=78
  10. en:administration of heavy metal antagonist -- r_associated #0: 77 / 0.41 -> en:administration, intravaginal
    n1=en:administration of heavy metal antagonist | n2=en:administration, intravaginal | rel=r_associated | relid=0 | w=77
  11. en:administration of heavy metal antagonist -- r_associated #0: 76 / 0.404 -> en:administration of analgesic
    n1=en:administration of heavy metal antagonist | n2=en:administration of analgesic | rel=r_associated | relid=0 | w=76
  12. en:administration of heavy metal antagonist -- r_associated #0: 76 / 0.404 -> en:administration of chemotherapeutic agent into bladder via intravesical route
    n1=en:administration of heavy metal antagonist | n2=en:administration of chemotherapeutic agent into bladder via intravesical route | rel=r_associated | relid=0 | w=76
  13. en:administration of heavy metal antagonist -- r_associated #0: 75 / 0.399 -> perfusion
    n1=en:administration of heavy metal antagonist | n2=perfusion | rel=r_associated | relid=0 | w=75
  14. en:administration of heavy metal antagonist -- r_associated #0: 74 / 0.394 -> en:administration of digitalis
    n1=en:administration of heavy metal antagonist | n2=en:administration of digitalis | rel=r_associated | relid=0 | w=74
  15. en:administration of heavy metal antagonist -- r_associated #0: 71 / 0.378 -> en:administration of antivenin
    n1=en:administration of heavy metal antagonist | n2=en:administration of antivenin | rel=r_associated | relid=0 | w=71
  16. en:administration of heavy metal antagonist -- r_associated #0: 61 / 0.324 -> injection
    n1=en:administration of heavy metal antagonist | n2=injection | rel=r_associated | relid=0 | w=61
  17. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:administration of radiopharmaceutical
    n1=en:administration of heavy metal antagonist | n2=en:administration of radiopharmaceutical | rel=r_associated | relid=0 | w=59
  18. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:epidural injection of neurolytic solution, lumbar
    n1=en:administration of heavy metal antagonist | n2=en:epidural injection of neurolytic solution, lumbar | rel=r_associated | relid=0 | w=59
  19. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:fluoroscopy guided injection of anesthetic into facet joint
    n1=en:administration of heavy metal antagonist | n2=en:fluoroscopy guided injection of anesthetic into facet joint | rel=r_associated | relid=0 | w=59
  20. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:giving aperient
    n1=en:administration of heavy metal antagonist | n2=en:giving aperient | rel=r_associated | relid=0 | w=59
  21. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:hypodermic drug injection
    n1=en:administration of heavy metal antagonist | n2=en:hypodermic drug injection | rel=r_associated | relid=0 | w=59
  22. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:inhalation drug administration
    n1=en:administration of heavy metal antagonist | n2=en:inhalation drug administration | rel=r_associated | relid=0 | w=59
  23. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:injection of anesthetic agent into pudendal nerve
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into pudendal nerve | rel=r_associated | relid=0 | w=59
  24. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:injection of local anesthetic and steroid into joint
    n1=en:administration of heavy metal antagonist | n2=en:injection of local anesthetic and steroid into joint | rel=r_associated | relid=0 | w=59
  25. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:injection of sclerosing agent
    n1=en:administration of heavy metal antagonist | n2=en:injection of sclerosing agent | rel=r_associated | relid=0 | w=59
  26. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:injection of thrombin using ultrasound guidance
    n1=en:administration of heavy metal antagonist | n2=en:injection of thrombin using ultrasound guidance | rel=r_associated | relid=0 | w=59
  27. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:intrathecal neurolytic injection
    n1=en:administration of heavy metal antagonist | n2=en:intrathecal neurolytic injection | rel=r_associated | relid=0 | w=59
  28. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:introduction of therapeutic substance into ligament of joint
    n1=en:administration of heavy metal antagonist | n2=en:introduction of therapeutic substance into ligament of joint | rel=r_associated | relid=0 | w=59
  29. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:leukovorin rescue
    n1=en:administration of heavy metal antagonist | n2=en:leukovorin rescue | rel=r_associated | relid=0 | w=59
  30. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:local anesthetic fascia iliac block
    n1=en:administration of heavy metal antagonist | n2=en:local anesthetic fascia iliac block | rel=r_associated | relid=0 | w=59
  31. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:lumbar plexus block
    n1=en:administration of heavy metal antagonist | n2=en:lumbar plexus block | rel=r_associated | relid=0 | w=59
  32. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:medication
    n1=en:administration of heavy metal antagonist | n2=en:medication | rel=r_associated | relid=0 | w=59
  33. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:medication administration: ventricular reservoir
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: ventricular reservoir | rel=r_associated | relid=0 | w=59
  34. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:nerve blocks, infiltrations and injections
    n1=en:administration of heavy metal antagonist | n2=en:nerve blocks, infiltrations and injections | rel=r_associated | relid=0 | w=59
  35. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:reduction of symphysis pubis dislocation with anesthesia and with manipulation
    n1=en:administration of heavy metal antagonist | n2=en:reduction of symphysis pubis dislocation with anesthesia and with manipulation | rel=r_associated | relid=0 | w=59
  36. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:sedation
    n1=en:administration of heavy metal antagonist | n2=en:sedation | rel=r_associated | relid=0 | w=59
  37. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:self administration
    n1=en:administration of heavy metal antagonist | n2=en:self administration | rel=r_associated | relid=0 | w=59
  38. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:skin infiltration of local anesthetic and steroid
    n1=en:administration of heavy metal antagonist | n2=en:skin infiltration of local anesthetic and steroid | rel=r_associated | relid=0 | w=59
  39. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:spinal injection of destructive agent
    n1=en:administration of heavy metal antagonist | n2=en:spinal injection of destructive agent | rel=r_associated | relid=0 | w=59
  40. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:subcutaneous drug therapy
    n1=en:administration of heavy metal antagonist | n2=en:subcutaneous drug therapy | rel=r_associated | relid=0 | w=59
  41. en:administration of heavy metal antagonist -- r_associated #0: 59 / 0.314 -> en:trabeculectomy with intraoperative application of antimetabolite
    n1=en:administration of heavy metal antagonist | n2=en:trabeculectomy with intraoperative application of antimetabolite | rel=r_associated | relid=0 | w=59
  42. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:cut-down injection
    n1=en:administration of heavy metal antagonist | n2=en:cut-down injection | rel=r_associated | relid=0 | w=58
  43. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:injection of iodine 131
    n1=en:administration of heavy metal antagonist | n2=en:injection of iodine 131 | rel=r_associated | relid=0 | w=58
  44. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:injection of therapeutic substance into fascia of hand
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance into fascia of hand | rel=r_associated | relid=0 | w=58
  45. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:injection of therapeutic substance into salivary gland
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance into salivary gland | rel=r_associated | relid=0 | w=58
  46. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:injection of thrombin into pseudoaneurysm of extremity
    n1=en:administration of heavy metal antagonist | n2=en:injection of thrombin into pseudoaneurysm of extremity | rel=r_associated | relid=0 | w=58
  47. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:intramyometrial injection of prostaglandin
    n1=en:administration of heavy metal antagonist | n2=en:intramyometrial injection of prostaglandin | rel=r_associated | relid=0 | w=58
  48. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:intrathecal injection of radiological dye
    n1=en:administration of heavy metal antagonist | n2=en:intrathecal injection of radiological dye | rel=r_associated | relid=0 | w=58
  49. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:medication administration: intraosseous
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: intraosseous | rel=r_associated | relid=0 | w=58
  50. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:percutaneous injection of renal cyst
    n1=en:administration of heavy metal antagonist | n2=en:percutaneous injection of renal cyst | rel=r_associated | relid=0 | w=58
  51. en:administration of heavy metal antagonist -- r_associated #0: 58 / 0.309 -> en:transfusion of pentastarch
    n1=en:administration of heavy metal antagonist | n2=en:transfusion of pentastarch | rel=r_associated | relid=0 | w=58
  52. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:administration of antitoxin
    n1=en:administration of heavy metal antagonist | n2=en:administration of antitoxin | rel=r_associated | relid=0 | w=57
  53. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:administration of aspirin
    n1=en:administration of heavy metal antagonist | n2=en:administration of aspirin | rel=r_associated | relid=0 | w=57
  54. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:administration of drug or medicament via ophthalmic route
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via ophthalmic route | rel=r_associated | relid=0 | w=57
  55. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:antineoplastic chemotherapy regimen
    n1=en:administration of heavy metal antagonist | n2=en:antineoplastic chemotherapy regimen | rel=r_associated | relid=0 | w=57
  56. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:celiac plexus block using fluoroscopic guidance
    n1=en:administration of heavy metal antagonist | n2=en:celiac plexus block using fluoroscopic guidance | rel=r_associated | relid=0 | w=57
  57. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:chemical sympathectomy using fluoroscopic guidance
    n1=en:administration of heavy metal antagonist | n2=en:chemical sympathectomy using fluoroscopic guidance | rel=r_associated | relid=0 | w=57
  58. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:cystoscopic injection of bupivacaine into ureter
    n1=en:administration of heavy metal antagonist | n2=en:cystoscopic injection of bupivacaine into ureter | rel=r_associated | relid=0 | w=57
  59. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:epidural injection of neurolytic solution, caudal
    n1=en:administration of heavy metal antagonist | n2=en:epidural injection of neurolytic solution, caudal | rel=r_associated | relid=0 | w=57
  60. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:fluoroscopy guided injection of thrombin
    n1=en:administration of heavy metal antagonist | n2=en:fluoroscopy guided injection of thrombin | rel=r_associated | relid=0 | w=57
  61. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:head artery cytotoxic injection
    n1=en:administration of heavy metal antagonist | n2=en:head artery cytotoxic injection | rel=r_associated | relid=0 | w=57
  62. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:immunization
    n1=en:administration of heavy metal antagonist | n2=en:immunization | rel=r_associated | relid=0 | w=57
  63. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of anesthetic agent into lumbar region
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into lumbar region | rel=r_associated | relid=0 | w=57
  64. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of anesthetic agent into peripheral nerve for analgesia
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into peripheral nerve for analgesia | rel=r_associated | relid=0 | w=57
  65. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of anesthetic agent into sciatic nerve
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into sciatic nerve | rel=r_associated | relid=0 | w=57
  66. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of anesthetic agent into thoracic nerve
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into thoracic nerve | rel=r_associated | relid=0 | w=57
  67. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of bone marrow for local action
    n1=en:administration of heavy metal antagonist | n2=en:injection of bone marrow for local action | rel=r_associated | relid=0 | w=57
  68. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of drug or medicament into macula
    n1=en:administration of heavy metal antagonist | n2=en:injection of drug or medicament into macula | rel=r_associated | relid=0 | w=57
  69. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of local anesthetic into sacroiliac joint
    n1=en:administration of heavy metal antagonist | n2=en:injection of local anesthetic into sacroiliac joint | rel=r_associated | relid=0 | w=57
  70. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of neurolytic substance into pituitary gland
    n1=en:administration of heavy metal antagonist | n2=en:injection of neurolytic substance into pituitary gland | rel=r_associated | relid=0 | w=57
  71. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of spinal saline
    n1=en:administration of heavy metal antagonist | n2=en:injection of spinal saline | rel=r_associated | relid=0 | w=57
  72. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of streptokinase
    n1=en:administration of heavy metal antagonist | n2=en:injection of streptokinase | rel=r_associated | relid=0 | w=57
  73. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of therapeutic substance into bladder wall
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance into bladder wall | rel=r_associated | relid=0 | w=57
  74. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:injection of thrombolytic agent direct into coronary artery
    n1=en:administration of heavy metal antagonist | n2=en:injection of thrombolytic agent direct into coronary artery | rel=r_associated | relid=0 | w=57
  75. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:intermittent infusion of therapeutic substance
    n1=en:administration of heavy metal antagonist | n2=en:intermittent infusion of therapeutic substance | rel=r_associated | relid=0 | w=57
  76. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:intra-arterial infusion of thrombolytic agent
    n1=en:administration of heavy metal antagonist | n2=en:intra-arterial infusion of thrombolytic agent | rel=r_associated | relid=0 | w=57
  77. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:intracavernous injection test using vaso-active agent
    n1=en:administration of heavy metal antagonist | n2=en:intracavernous injection test using vaso-active agent | rel=r_associated | relid=0 | w=57
  78. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:intrathecal injection of chemotherapeutic agent
    n1=en:administration of heavy metal antagonist | n2=en:intrathecal injection of chemotherapeutic agent | rel=r_associated | relid=0 | w=57
  79. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:local anesthetic block of spinal nerve root using fluoroscopic guidance
    n1=en:administration of heavy metal antagonist | n2=en:local anesthetic block of spinal nerve root using fluoroscopic guidance | rel=r_associated | relid=0 | w=57
  80. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:local anesthetic popliteal fossa block
    n1=en:administration of heavy metal antagonist | n2=en:local anesthetic popliteal fossa block | rel=r_associated | relid=0 | w=57
  81. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:medication administration: intravenous
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: intravenous | rel=r_associated | relid=0 | w=57
  82. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:pharmacotherapy
    n1=en:administration of heavy metal antagonist | n2=en:pharmacotherapy | rel=r_associated | relid=0 | w=57
  83. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:reduction of atraumatic hip dislocation with general anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:reduction of atraumatic hip dislocation with general anesthesia | rel=r_associated | relid=0 | w=57
  84. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:reduction of closed tarsometatarsal joint dislocation with anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:reduction of closed tarsometatarsal joint dislocation with anesthesia | rel=r_associated | relid=0 | w=57
  85. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:reduction of closed traumatic hip dislocation with anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:reduction of closed traumatic hip dislocation with anesthesia | rel=r_associated | relid=0 | w=57
  86. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:repair of pseudoaneurysm by injection of thrombin
    n1=en:administration of heavy metal antagonist | n2=en:repair of pseudoaneurysm by injection of thrombin | rel=r_associated | relid=0 | w=57
  87. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:respiratory medication
    n1=en:administration of heavy metal antagonist | n2=en:respiratory medication | rel=r_associated | relid=0 | w=57
  88. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:retrobulbar injection of anesthetic agent
    n1=en:administration of heavy metal antagonist | n2=en:retrobulbar injection of anesthetic agent | rel=r_associated | relid=0 | w=57
  89. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:retrobulbar injection of therapeutic agent
    n1=en:administration of heavy metal antagonist | n2=en:retrobulbar injection of therapeutic agent | rel=r_associated | relid=0 | w=57
  90. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:scar infiltration of neurolytic substance
    n1=en:administration of heavy metal antagonist | n2=en:scar infiltration of neurolytic substance | rel=r_associated | relid=0 | w=57
  91. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:special administration of medication
    n1=en:administration of heavy metal antagonist | n2=en:special administration of medication | rel=r_associated | relid=0 | w=57
  92. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:sphenopalatine ganglion block
    n1=en:administration of heavy metal antagonist | n2=en:sphenopalatine ganglion block | rel=r_associated | relid=0 | w=57
  93. en:administration of heavy metal antagonist -- r_associated #0: 57 / 0.303 -> en:spinal block
    n1=en:administration of heavy metal antagonist | n2=en:spinal block | rel=r_associated | relid=0 | w=57
  94. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration - action
    n1=en:administration of heavy metal antagonist | n2=en:administration - action | rel=r_associated | relid=0 | w=56
  95. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration of drug or medicament to skin via topical route
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament to skin via topical route | rel=r_associated | relid=0 | w=56
  96. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration of muscle relaxant
    n1=en:administration of heavy metal antagonist | n2=en:administration of muscle relaxant | rel=r_associated | relid=0 | w=56
  97. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration of prescribed medications and solutions
    n1=en:administration of heavy metal antagonist | n2=en:administration of prescribed medications and solutions | rel=r_associated | relid=0 | w=56
  98. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration of vitamin
    n1=en:administration of heavy metal antagonist | n2=en:administration of vitamin | rel=r_associated | relid=0 | w=56
  99. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:administration, intranasal
    n1=en:administration of heavy metal antagonist | n2=en:administration, intranasal | rel=r_associated | relid=0 | w=56
  100. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:celiac plexus block using ultrasound guidance
    n1=en:administration of heavy metal antagonist | n2=en:celiac plexus block using ultrasound guidance | rel=r_associated | relid=0 | w=56
  101. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:chemical labyrinthectomy
    n1=en:administration of heavy metal antagonist | n2=en:chemical labyrinthectomy | rel=r_associated | relid=0 | w=56
  102. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:emergency administration of medication
    n1=en:administration of heavy metal antagonist | n2=en:emergency administration of medication | rel=r_associated | relid=0 | w=56
  103. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection into bursa
    n1=en:administration of heavy metal antagonist | n2=en:injection into bursa | rel=r_associated | relid=0 | w=56
  104. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection of collagen
    n1=en:administration of heavy metal antagonist | n2=en:injection of collagen | rel=r_associated | relid=0 | w=56
  105. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection of depot antipsychotic agent
    n1=en:administration of heavy metal antagonist | n2=en:injection of depot antipsychotic agent | rel=r_associated | relid=0 | w=56
  106. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection of medication in anterior chamber of eye
    n1=en:administration of heavy metal antagonist | n2=en:injection of medication in anterior chamber of eye | rel=r_associated | relid=0 | w=56
  107. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection of therapeutic substance around the eye
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance around the eye | rel=r_associated | relid=0 | w=56
  108. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:injection of therapeutic substance into heart
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance into heart | rel=r_associated | relid=0 | w=56
  109. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:intracardiac potassium chloride injection
    n1=en:administration of heavy metal antagonist | n2=en:intracardiac potassium chloride injection | rel=r_associated | relid=0 | w=56
  110. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:intraperitoneal administration of cytotoxic drug
    n1=en:administration of heavy metal antagonist | n2=en:intraperitoneal administration of cytotoxic drug | rel=r_associated | relid=0 | w=56
  111. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:intravenous fluid replacement
    n1=en:administration of heavy metal antagonist | n2=en:intravenous fluid replacement | rel=r_associated | relid=0 | w=56
  112. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:iontophoresis administration of treatment
    n1=en:administration of heavy metal antagonist | n2=en:iontophoresis administration of treatment | rel=r_associated | relid=0 | w=56
  113. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:ipecac emesis administration and observation
    n1=en:administration of heavy metal antagonist | n2=en:ipecac emesis administration and observation | rel=r_associated | relid=0 | w=56
  114. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:manual reduction of dislocation of sacroiliac joint under anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:manual reduction of dislocation of sacroiliac joint under anesthesia | rel=r_associated | relid=0 | w=56
  115. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:medication administration: intradermal
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: intradermal | rel=r_associated | relid=0 | w=56
  116. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:medication administration: intramuscular
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: intramuscular | rel=r_associated | relid=0 | w=56
  117. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:peridural injection
    n1=en:administration of heavy metal antagonist | n2=en:peridural injection | rel=r_associated | relid=0 | w=56
  118. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:routine administration of medication
    n1=en:administration of heavy metal antagonist | n2=en:routine administration of medication | rel=r_associated | relid=0 | w=56
  119. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:skin infiltration of neurolytic substance
    n1=en:administration of heavy metal antagonist | n2=en:skin infiltration of neurolytic substance | rel=r_associated | relid=0 | w=56
  120. en:administration of heavy metal antagonist -- r_associated #0: 56 / 0.298 -> en:trigger point infiltration of local anesthetic and steroid
    n1=en:administration of heavy metal antagonist | n2=en:trigger point infiltration of local anesthetic and steroid | rel=r_associated | relid=0 | w=56
  121. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of anti-infective agent
    n1=en:administration of heavy metal antagonist | n2=en:administration of anti-infective agent | rel=r_associated | relid=0 | w=55
  122. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of antidote
    n1=en:administration of heavy metal antagonist | n2=en:administration of antidote | rel=r_associated | relid=0 | w=55
  123. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of dermatologic formulation
    n1=en:administration of heavy metal antagonist | n2=en:administration of dermatologic formulation | rel=r_associated | relid=0 | w=55
  124. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of drug or medicament via intraarterial route
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via intraarterial route | rel=r_associated | relid=0 | w=55
  125. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of drug or medicament via rectal route (procedure)
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via rectal route (procedure) | rel=r_associated | relid=0 | w=55
  126. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:administration of nutritional supplement
    n1=en:administration of heavy metal antagonist | n2=en:administration of nutritional supplement | rel=r_associated | relid=0 | w=55
  127. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:diagnostic dye introduction
    n1=en:administration of heavy metal antagonist | n2=en:diagnostic dye introduction | rel=r_associated | relid=0 | w=55
  128. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:fetal intracardiac injection of potassium chloride
    n1=en:administration of heavy metal antagonist | n2=en:fetal intracardiac injection of potassium chloride | rel=r_associated | relid=0 | w=55
  129. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:guanethidine block
    n1=en:administration of heavy metal antagonist | n2=en:guanethidine block | rel=r_associated | relid=0 | w=55
  130. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:injection of dye into breast using ultrasound guidance
    n1=en:administration of heavy metal antagonist | n2=en:injection of dye into breast using ultrasound guidance | rel=r_associated | relid=0 | w=55
  131. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:injection of strontium-89
    n1=en:administration of heavy metal antagonist | n2=en:injection of strontium-89 | rel=r_associated | relid=0 | w=55
  132. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:injection of therapeutic substance into penis
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance into penis | rel=r_associated | relid=0 | w=55
  133. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:injection of urokinase
    n1=en:administration of heavy metal antagonist | n2=en:injection of urokinase | rel=r_associated | relid=0 | w=55
  134. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:intra-arterial infusion of therapeutic substance
    n1=en:administration of heavy metal antagonist | n2=en:intra-arterial infusion of therapeutic substance | rel=r_associated | relid=0 | w=55
  135. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:intramuscular drug injection
    n1=en:administration of heavy metal antagonist | n2=en:intramuscular drug injection | rel=r_associated | relid=0 | w=55
  136. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:manual reduction of closed dislocation of shoulder joint under anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:manual reduction of closed dislocation of shoulder joint under anesthesia | rel=r_associated | relid=0 | w=55
  137. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:medication administration during home visit
    n1=en:administration of heavy metal antagonist | n2=en:medication administration during home visit | rel=r_associated | relid=0 | w=55
  138. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:medication administration: intrathecal
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: intrathecal | rel=r_associated | relid=0 | w=55
  139. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:medication administration: subcutaneous
    n1=en:administration of heavy metal antagonist | n2=en:medication administration: subcutaneous | rel=r_associated | relid=0 | w=55
  140. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:reduction of closed talotarsal joint dislocation with anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:reduction of closed talotarsal joint dislocation with anesthesia | rel=r_associated | relid=0 | w=55
  141. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:scar infiltration of local anesthetic and steroid
    n1=en:administration of heavy metal antagonist | n2=en:scar infiltration of local anesthetic and steroid | rel=r_associated | relid=0 | w=55
  142. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:transfusion of cryoprecipitate
    n1=en:administration of heavy metal antagonist | n2=en:transfusion of cryoprecipitate | rel=r_associated | relid=0 | w=55
  143. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:transfusion of dextran
    n1=en:administration of heavy metal antagonist | n2=en:transfusion of dextran | rel=r_associated | relid=0 | w=55
  144. en:administration of heavy metal antagonist -- r_associated #0: 55 / 0.293 -> en:viscosupplementation
    n1=en:administration of heavy metal antagonist | n2=en:viscosupplementation | rel=r_associated | relid=0 | w=55
  145. en:administration of heavy metal antagonist -- r_associated #0: 54 / 0.287 -> en:antihemophilic factor transfusion
    n1=en:administration of heavy metal antagonist | n2=en:antihemophilic factor transfusion | rel=r_associated | relid=0 | w=54
  146. en:administration of heavy metal antagonist -- r_associated #0: 54 / 0.287 -> en:continuous infusion of therapeutic substance
    n1=en:administration of heavy metal antagonist | n2=en:continuous infusion of therapeutic substance | rel=r_associated | relid=0 | w=54
  147. en:administration of heavy metal antagonist -- r_associated #0: 54 / 0.287 -> en:epidural block
    n1=en:administration of heavy metal antagonist | n2=en:epidural block | rel=r_associated | relid=0 | w=54
  148. en:administration of heavy metal antagonist -- r_associated #0: 54 / 0.287 -> en:injection of local anesthetic into facet joint
    n1=en:administration of heavy metal antagonist | n2=en:injection of local anesthetic into facet joint | rel=r_associated | relid=0 | w=54
  149. en:administration of heavy metal antagonist -- r_associated #0: 54 / 0.287 -> en:ocular infiltration of local anesthetic
    n1=en:administration of heavy metal antagonist | n2=en:ocular infiltration of local anesthetic | rel=r_associated | relid=0 | w=54
  150. en:administration of heavy metal antagonist -- r_associated #0: 53 / 0.282 -> en:administration of sulfonylurea
    n1=en:administration of heavy metal antagonist | n2=en:administration of sulfonylurea | rel=r_associated | relid=0 | w=53
  151. en:administration of heavy metal antagonist -- r_associated #0: 53 / 0.282 -> en:intra-arterial infusion of prophylactic substance
    n1=en:administration of heavy metal antagonist | n2=en:intra-arterial infusion of prophylactic substance | rel=r_associated | relid=0 | w=53
  152. en:administration of heavy metal antagonist -- r_associated #0: 53 / 0.282 -> en:introduction of therapeutic substance into vein
    n1=en:administration of heavy metal antagonist | n2=en:introduction of therapeutic substance into vein | rel=r_associated | relid=0 | w=53
  153. en:administration of heavy metal antagonist -- r_associated #0: 53 / 0.282 -> en:neural block
    n1=en:administration of heavy metal antagonist | n2=en:neural block | rel=r_associated | relid=0 | w=53
  154. en:administration of heavy metal antagonist -- r_associated #0: 53 / 0.282 -> en:sympathetic block
    n1=en:administration of heavy metal antagonist | n2=en:sympathetic block | rel=r_associated | relid=0 | w=53
  155. en:administration of heavy metal antagonist -- r_associated #0: 52 / 0.277 -> en:injection of anesthetic agent into carotid sinus
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into carotid sinus | rel=r_associated | relid=0 | w=52
  156. en:administration of heavy metal antagonist -- r_associated #0: 52 / 0.277 -> en:injection of phosphorus 32
    n1=en:administration of heavy metal antagonist | n2=en:injection of phosphorus 32 | rel=r_associated | relid=0 | w=52
  157. en:administration of heavy metal antagonist -- r_associated #0: 52 / 0.277 -> en:reduction of closed elbow dislocation requiring anesthesia
    n1=en:administration of heavy metal antagonist | n2=en:reduction of closed elbow dislocation requiring anesthesia | rel=r_associated | relid=0 | w=52
  158. en:administration of heavy metal antagonist -- r_associated #0: 51 / 0.271 -> en:administration, oral
    n1=en:administration of heavy metal antagonist | n2=en:administration, oral | rel=r_associated | relid=0 | w=51
  159. en:administration of heavy metal antagonist -- r_associated #0: 51 / 0.271 -> en:infusion of steroid
    n1=en:administration of heavy metal antagonist | n2=en:infusion of steroid | rel=r_associated | relid=0 | w=51
  160. en:administration of heavy metal antagonist -- r_associated #0: 51 / 0.271 -> en:injection of anesthetic into periorbital region for akinesia
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic into periorbital region for akinesia | rel=r_associated | relid=0 | w=51
  161. en:administration of heavy metal antagonist -- r_associated #0: 51 / 0.271 -> en:intraperitoneal immunotherapy
    n1=en:administration of heavy metal antagonist | n2=en:intraperitoneal immunotherapy | rel=r_associated | relid=0 | w=51
  162. en:administration of heavy metal antagonist -- r_associated #0: 40 / 0.213 -> en:administration
    n1=en:administration of heavy metal antagonist | n2=en:administration | rel=r_associated | relid=0 | w=40
  163. en:administration of heavy metal antagonist -- r_associated #0: 38 / 0.202 -> en:medical procedure
    n1=en:administration of heavy metal antagonist | n2=en:medical procedure | rel=r_associated | relid=0 | w=38
  164. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:administration of drug or medicament via enteral tube
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via enteral tube | rel=r_associated | relid=0 | w=35
  165. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:administration of prescribed medications based on arterial blood gas results
    n1=en:administration of heavy metal antagonist | n2=en:administration of prescribed medications based on arterial blood gas results | rel=r_associated | relid=0 | w=35
  166. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:administration of tranquilizer
    n1=en:administration of heavy metal antagonist | n2=en:administration of tranquilizer | rel=r_associated | relid=0 | w=35
  167. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:anesthesia procedure
    n1=en:administration of heavy metal antagonist | n2=en:anesthesia procedure | rel=r_associated | relid=0 | w=35
  168. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:injection of anesthetic agent into vagus nerve
    n1=en:administration of heavy metal antagonist | n2=en:injection of anesthetic agent into vagus nerve | rel=r_associated | relid=0 | w=35
  169. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:injection of neurolytic substance, subarachnoid
    n1=en:administration of heavy metal antagonist | n2=en:injection of neurolytic substance, subarachnoid | rel=r_associated | relid=0 | w=35
  170. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:injection of therapeutic substance around sympathetic nerve
    n1=en:administration of heavy metal antagonist | n2=en:injection of therapeutic substance around sympathetic nerve | rel=r_associated | relid=0 | w=35
  171. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:methotrexate injection into tubal pregnancy
    n1=en:administration of heavy metal antagonist | n2=en:methotrexate injection into tubal pregnancy | rel=r_associated | relid=0 | w=35
  172. en:administration of heavy metal antagonist -- r_associated #0: 35 / 0.186 -> en:transfusion antithrombin iii factor
    n1=en:administration of heavy metal antagonist | n2=en:transfusion antithrombin iii factor | rel=r_associated | relid=0 | w=35
  173. en:administration of heavy metal antagonist -- r_associated #0: 30 / 0.16 -> en:administration of drug or medicament via otic route
    n1=en:administration of heavy metal antagonist | n2=en:administration of drug or medicament via otic route | rel=r_associated | relid=0 | w=30
  174. en:administration of heavy metal antagonist -- r_associated #0: 27 / 0.144 -> préparation pharmaceutique
    n1=en:administration of heavy metal antagonist | n2=préparation pharmaceutique | rel=r_associated | relid=0 | w=27
  175. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> administration d'anticoagulant
    n1=en:administration of heavy metal antagonist | n2=administration d'anticoagulant | rel=r_associated | relid=0 | w=20
  176. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> administration d'antidote
    n1=en:administration of heavy metal antagonist | n2=administration d'antidote | rel=r_associated | relid=0 | w=20
  177. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> administration de routine d'un médicament
    n1=en:administration of heavy metal antagonist | n2=administration de routine d'un médicament | rel=r_associated | relid=0 | w=20
  178. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> administration de tranquilisant
    n1=en:administration of heavy metal antagonist | n2=administration de tranquilisant | rel=r_associated | relid=0 | w=20
  179. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> en:administration of heat treated rabies immune globulin
    n1=en:administration of heavy metal antagonist | n2=en:administration of heat treated rabies immune globulin | rel=r_associated | relid=0 | w=20
  180. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> en:administration of herpes zoster vaccine
    n1=en:administration of heavy metal antagonist | n2=en:administration of herpes zoster vaccine | rel=r_associated | relid=0 | w=20
  181. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> en:administration of human papilloma virus type 16 and type 18 vaccine
    n1=en:administration of heavy metal antagonist | n2=en:administration of human papilloma virus type 16 and type 18 vaccine | rel=r_associated | relid=0 | w=20
  182. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> injection d'agent anesthésique dans la région lombaire
    n1=en:administration of heavy metal antagonist | n2=injection d'agent anesthésique dans la région lombaire | rel=r_associated | relid=0 | w=20
  183. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> injection d'agent anesthésique dans le nerf sciatique
    n1=en:administration of heavy metal antagonist | n2=injection d'agent anesthésique dans le nerf sciatique | rel=r_associated | relid=0 | w=20
  184. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> injection d'agent anesthésique dans le nerf vague
    n1=en:administration of heavy metal antagonist | n2=injection d'agent anesthésique dans le nerf vague | rel=r_associated | relid=0 | w=20
  185. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> injection d'anticoagulant
    n1=en:administration of heavy metal antagonist | n2=injection d'anticoagulant | rel=r_associated | relid=0 | w=20
  186. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> injection d'antidote
    n1=en:administration of heavy metal antagonist | n2=injection d'antidote | rel=r_associated | relid=0 | w=20
  187. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> perfusion d'anticoagulant
    n1=en:administration of heavy metal antagonist | n2=perfusion d'anticoagulant | rel=r_associated | relid=0 | w=20
  188. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> perfusion d'antidote
    n1=en:administration of heavy metal antagonist | n2=perfusion d'antidote | rel=r_associated | relid=0 | w=20
  189. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> réduction de luxation fermée du coude nécessitant une anesthésie
    n1=en:administration of heavy metal antagonist | n2=réduction de luxation fermée du coude nécessitant une anesthésie | rel=r_associated | relid=0 | w=20
  190. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> transfusion de dextran
    n1=en:administration of heavy metal antagonist | n2=transfusion de dextran | rel=r_associated | relid=0 | w=20
  191. en:administration of heavy metal antagonist -- r_associated #0: 20 / 0.106 -> transfusion de facteur antihémophilique
    n1=en:administration of heavy metal antagonist | n2=transfusion de facteur antihémophilique | rel=r_associated | relid=0 | w=20
  192. en:administration of heavy metal antagonist -- r_associated #0: 5 / 0.027 -> Médecine
    n1=en:administration of heavy metal antagonist | n2=Médecine | rel=r_associated | relid=0 | w=5
  193. en:administration of heavy metal antagonist -- r_associated #0: 5 / 0.027 -> métal lourd
    n1=en:administration of heavy metal antagonist | n2=métal lourd | rel=r_associated | relid=0 | w=5
  194. en:administration of heavy metal antagonist -- r_associated #0: 1 / 0.005 -> administration
    n1=en:administration of heavy metal antagonist | n2=administration | rel=r_associated | relid=0 | w=1
≈ 209 relations entrantes

  1. médecine --- r_associated #0: 173 --> en:administration of heavy metal antagonist
    n1=médecine | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=173
  2. en:injection of anesthetic agent into vagus nerve --- r_associated #0: 125 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into vagus nerve | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=125
  3. injection d'agent anesthésique dans le nerf vague --- r_associated #0: 124 --> en:administration of heavy metal antagonist
    n1=injection d'agent anesthésique dans le nerf vague | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=124
  4. administration d'anticoagulant --- r_associated #0: 75 --> en:administration of heavy metal antagonist
    n1=administration d'anticoagulant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=75
  5. perfusion d'anticoagulant --- r_associated #0: 75 --> en:administration of heavy metal antagonist
    n1=perfusion d'anticoagulant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=75
  6. injection de l'antagoniste d'un métal lourd --- r_associated #0: 72 --> en:administration of heavy metal antagonist
    n1=injection de l'antagoniste d'un métal lourd | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=72
  7. en:administration of anticoagulant --- r_associated #0: 71 --> en:administration of heavy metal antagonist
    n1=en:administration of anticoagulant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=71
  8. administration de l'antagoniste d'un métal lourd --- r_associated #0: 68 --> en:administration of heavy metal antagonist
    n1=administration de l'antagoniste d'un métal lourd | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=68
  9. injection d'anticoagulant --- r_associated #0: 68 --> en:administration of heavy metal antagonist
    n1=injection d'anticoagulant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=68
  10. en:routine administration of medication --- r_associated #0: 63 --> en:administration of heavy metal antagonist
    n1=en:routine administration of medication | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=63
  11. perfusion de l'antagoniste d'un métal lourd --- r_associated #0: 63 --> en:administration of heavy metal antagonist
    n1=perfusion de l'antagoniste d'un métal lourd | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=63
  12. administration de routine d'un médicament --- r_associated #0: 62 --> en:administration of heavy metal antagonist
    n1=administration de routine d'un médicament | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=62
  13. en:injection of anesthetic agent into sciatic nerve --- r_associated #0: 61 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into sciatic nerve | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=61
  14. administration de tranquilisant --- r_associated #0: 60 --> en:administration of heavy metal antagonist
    n1=administration de tranquilisant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=60
  15. injection d'agent anesthésique dans le nerf sciatique --- r_associated #0: 58 --> en:administration of heavy metal antagonist
    n1=injection d'agent anesthésique dans le nerf sciatique | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=58
  16. en:administration of tranquilizer --- r_associated #0: 54 --> en:administration of heavy metal antagonist
    n1=en:administration of tranquilizer | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=54
  17. en:antihemophilic factor transfusion --- r_associated #0: 52 --> en:administration of heavy metal antagonist
    n1=en:antihemophilic factor transfusion | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=52
  18. en:reduction of closed elbow dislocation requiring anesthesia --- r_associated #0: 52 --> en:administration of heavy metal antagonist
    n1=en:reduction of closed elbow dislocation requiring anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=52
  19. réduction de luxation fermée du coude nécessitant une anesthésie --- r_associated #0: 50 --> en:administration of heavy metal antagonist
    n1=réduction de luxation fermée du coude nécessitant une anesthésie | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=50
  20. transfusion de facteur antihémophilique --- r_associated #0: 50 --> en:administration of heavy metal antagonist
    n1=transfusion de facteur antihémophilique | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=50
  21. en:transfusion of dextran --- r_associated #0: 46 --> en:administration of heavy metal antagonist
    n1=en:transfusion of dextran | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=46
  22. injection d'antidote --- r_associated #0: 45 --> en:administration of heavy metal antagonist
    n1=injection d'antidote | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=45
  23. perfusion d'antidote --- r_associated #0: 45 --> en:administration of heavy metal antagonist
    n1=perfusion d'antidote | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=45
  24. en:reduction of closed traumatic hip dislocation with anesthesia --- r_associated #0: 43 --> en:administration of heavy metal antagonist
    n1=en:reduction of closed traumatic hip dislocation with anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=43
  25. en:intra-arterial infusion of thrombolytic agent --- r_associated #0: 42 --> en:administration of heavy metal antagonist
    n1=en:intra-arterial infusion of thrombolytic agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=42
  26. en:intrathecal neurolytic injection --- r_associated #0: 42 --> en:administration of heavy metal antagonist
    n1=en:intrathecal neurolytic injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=42
  27. en:administration of antidote --- r_associated #0: 41 --> en:administration of heavy metal antagonist
    n1=en:administration of antidote | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=41
  28. en:reduction of closed talotarsal joint dislocation with anesthesia --- r_associated #0: 41 --> en:administration of heavy metal antagonist
    n1=en:reduction of closed talotarsal joint dislocation with anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=41
  29. administration d'antidote --- r_associated #0: 40 --> en:administration of heavy metal antagonist
    n1=administration d'antidote | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=40
  30. en:repair of pseudoaneurysm by injection of thrombin --- r_associated #0: 40 --> en:administration of heavy metal antagonist
    n1=en:repair of pseudoaneurysm by injection of thrombin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=40
  31. transfusion de dextran --- r_associated #0: 40 --> en:administration of heavy metal antagonist
    n1=transfusion de dextran | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=40
  32. en:emergency administration of medication --- r_associated #0: 39 --> en:administration of heavy metal antagonist
    n1=en:emergency administration of medication | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=39
  33. en:intramyometrial injection of prostaglandin --- r_associated #0: 38 --> en:administration of heavy metal antagonist
    n1=en:intramyometrial injection of prostaglandin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=38
  34. en:chemical sympathectomy using fluoroscopic guidance --- r_associated #0: 35 --> en:administration of heavy metal antagonist
    n1=en:chemical sympathectomy using fluoroscopic guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=35
  35. en:intrathecal injection of chemotherapeutic agent --- r_associated #0: 35 --> en:administration of heavy metal antagonist
    n1=en:intrathecal injection of chemotherapeutic agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=35
  36. en:intrathecal injection of radiological dye --- r_associated #0: 35 --> en:administration of heavy metal antagonist
    n1=en:intrathecal injection of radiological dye | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=35
  37. en:local anesthetic block of spinal nerve root using fluoroscopic guidance --- r_associated #0: 35 --> en:administration of heavy metal antagonist
    n1=en:local anesthetic block of spinal nerve root using fluoroscopic guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=35
  38. en:trigger point infiltration of local anesthetic and steroid --- r_associated #0: 35 --> en:administration of heavy metal antagonist
    n1=en:trigger point infiltration of local anesthetic and steroid | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=35
  39. en:celiac plexus block using fluoroscopic guidance --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:celiac plexus block using fluoroscopic guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  40. en:fetal intracardiac injection of potassium chloride --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:fetal intracardiac injection of potassium chloride | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  41. en:head artery cytotoxic injection --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:head artery cytotoxic injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  42. en:injection of anesthetic agent into lumbar region --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into lumbar region | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  43. en:intramuscular drug injection --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:intramuscular drug injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  44. en:ipecac emesis administration and observation --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:ipecac emesis administration and observation | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  45. en:medication administration: ventricular reservoir --- r_associated #0: 34 --> en:administration of heavy metal antagonist
    n1=en:medication administration: ventricular reservoir | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=34
  46. en:administration of herpes zoster vaccine --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:administration of herpes zoster vaccine | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  47. en:administration of vitamin --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:administration of vitamin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  48. en:chemical labyrinthectomy --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:chemical labyrinthectomy | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  49. en:injection of anesthetic agent into carotid sinus --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into carotid sinus | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  50. en:injection of local anesthetic into facet joint --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:injection of local anesthetic into facet joint | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  51. en:intraperitoneal immunotherapy --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:intraperitoneal immunotherapy | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  52. en:manual reduction of dislocation of sacroiliac joint under anesthesia --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:manual reduction of dislocation of sacroiliac joint under anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  53. en:peridural injection --- r_associated #0: 32 --> en:administration of heavy metal antagonist
    n1=en:peridural injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=32
  54. en:administration of dermatologic formulation --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:administration of dermatologic formulation | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  55. en:administration of drug or medicament via enteral tube --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via enteral tube | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  56. en:cystoscopic injection of bupivacaine into ureter --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:cystoscopic injection of bupivacaine into ureter | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  57. en:epidural injection of neurolytic solution, caudal --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:epidural injection of neurolytic solution, caudal | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  58. en:epidural injection of neurolytic solution, lumbar --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:epidural injection of neurolytic solution, lumbar | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  59. en:guanethidine block --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:guanethidine block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  60. en:hypodermic drug injection --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:hypodermic drug injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  61. en:injection of anesthetic into periorbital region for akinesia --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic into periorbital region for akinesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  62. en:injection of neurolytic substance into pituitary gland --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:injection of neurolytic substance into pituitary gland | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  63. en:injection of neurolytic substance, subarachnoid --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:injection of neurolytic substance, subarachnoid | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  64. en:intra-arterial infusion of therapeutic substance --- r_associated #0: 31 --> en:administration of heavy metal antagonist
    n1=en:intra-arterial infusion of therapeutic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=31
  65. en:cut-down injection --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:cut-down injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  66. en:fluoroscopy guided injection of thrombin --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:fluoroscopy guided injection of thrombin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  67. en:injection of anesthetic agent into peripheral nerve for analgesia --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into peripheral nerve for analgesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  68. en:injection of anesthetic agent into thoracic nerve --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into thoracic nerve | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  69. en:injection of iodine 131 --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:injection of iodine 131 | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  70. en:injection of medication in anterior chamber of eye --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:injection of medication in anterior chamber of eye | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  71. en:intraperitoneal administration of cytotoxic drug --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:intraperitoneal administration of cytotoxic drug | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  72. en:leukovorin rescue --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:leukovorin rescue | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  73. en:retrobulbar injection of therapeutic agent --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=en:retrobulbar injection of therapeutic agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  74. injection d'agent anesthésique dans la région lombaire --- r_associated #0: 30 --> en:administration of heavy metal antagonist
    n1=injection d'agent anesthésique dans la région lombaire | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=30
  75. en:injection of dye into breast using ultrasound guidance --- r_associated #0: 29 --> en:administration of heavy metal antagonist
    n1=en:injection of dye into breast using ultrasound guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=29
  76. en:injection of phosphorus 32 --- r_associated #0: 29 --> en:administration of heavy metal antagonist
    n1=en:injection of phosphorus 32 | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=29
  77. en:intra-arterial infusion of prophylactic substance --- r_associated #0: 29 --> en:administration of heavy metal antagonist
    n1=en:intra-arterial infusion of prophylactic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=29
  78. en:scar infiltration of neurolytic substance --- r_associated #0: 29 --> en:administration of heavy metal antagonist
    n1=en:scar infiltration of neurolytic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=29
  79. en:administration of prescribed medications based on arterial blood gas results --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:administration of prescribed medications based on arterial blood gas results | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  80. en:injection of bone marrow for local action --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:injection of bone marrow for local action | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  81. en:injection of local anesthetic into sacroiliac joint --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:injection of local anesthetic into sacroiliac joint | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  82. en:injection of therapeutic substance into fascia of hand --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance into fascia of hand | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  83. en:intracavernous injection test using vaso-active agent --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:intracavernous injection test using vaso-active agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  84. en:nerve blocks, infiltrations and injections --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:nerve blocks, infiltrations and injections | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  85. en:ocular infiltration of local anesthetic --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:ocular infiltration of local anesthetic | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  86. en:reduction of closed tarsometatarsal joint dislocation with anesthesia --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:reduction of closed tarsometatarsal joint dislocation with anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  87. en:respiratory medication --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:respiratory medication | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  88. en:skin infiltration of local anesthetic and steroid --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:skin infiltration of local anesthetic and steroid | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  89. en:skin infiltration of neurolytic substance --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:skin infiltration of neurolytic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  90. en:spinal injection of destructive agent --- r_associated #0: 28 --> en:administration of heavy metal antagonist
    n1=en:spinal injection of destructive agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=28
  91. en:administration of heat treated rabies immune globulin --- r_associated #0: 27 --> en:administration of heavy metal antagonist
    n1=en:administration of heat treated rabies immune globulin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=27
  92. en:injection of thrombin into pseudoaneurysm of extremity --- r_associated #0: 27 --> en:administration of heavy metal antagonist
    n1=en:injection of thrombin into pseudoaneurysm of extremity | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=27
  93. en:intracardiac potassium chloride injection --- r_associated #0: 27 --> en:administration of heavy metal antagonist
    n1=en:intracardiac potassium chloride injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=27
  94. en:medication administration: intraosseous --- r_associated #0: 27 --> en:administration of heavy metal antagonist
    n1=en:medication administration: intraosseous | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=27
  95. en:medication administration: intrathecal --- r_associated #0: 27 --> en:administration of heavy metal antagonist
    n1=en:medication administration: intrathecal | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=27
  96. en:administration of antivenin --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:administration of antivenin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  97. en:administration of drug or medicament via rectal route (procedure) --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via rectal route (procedure) | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  98. en:administration of human papilloma virus type 16 and type 18 vaccine --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:administration of human papilloma virus type 16 and type 18 vaccine | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  99. en:administration of nutritional supplement --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:administration of nutritional supplement | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  100. en:antineoplastic chemotherapy regimen --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:antineoplastic chemotherapy regimen | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  101. en:celiac plexus block using ultrasound guidance --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:celiac plexus block using ultrasound guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  102. en:fluoroscopy guided injection of anesthetic into facet joint --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:fluoroscopy guided injection of anesthetic into facet joint | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  103. en:injection of local anesthetic and steroid into joint --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:injection of local anesthetic and steroid into joint | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  104. en:local anesthetic fascia iliac block --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:local anesthetic fascia iliac block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  105. en:medication --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:medication | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  106. en:methotrexate injection into tubal pregnancy --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:methotrexate injection into tubal pregnancy | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  107. en:percutaneous injection of renal cyst --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:percutaneous injection of renal cyst | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  108. en:reduction of atraumatic hip dislocation with general anesthesia --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:reduction of atraumatic hip dislocation with general anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  109. en:scar infiltration of local anesthetic and steroid --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:scar infiltration of local anesthetic and steroid | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  110. en:sympathetic block --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:sympathetic block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  111. en:viscosupplementation --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=en:viscosupplementation | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  112. préparation pharmaceutique --- r_associated #0: 26 --> en:administration of heavy metal antagonist
    n1=préparation pharmaceutique | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=26
  113. en:administration - action --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration - action | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  114. en:administration of analgesic --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of analgesic | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  115. en:administration of anti-infective agent --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of anti-infective agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  116. en:administration of antipyretic --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of antipyretic | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  117. en:administration of antitoxin --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of antitoxin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  118. en:administration of aspirin --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of aspirin | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  119. en:administration of chemotherapeutic agent into bladder via intravesical route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of chemotherapeutic agent into bladder via intravesical route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  120. en:administration of digitalis --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of digitalis | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  121. en:administration of drug or medicament to skin via topical route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament to skin via topical route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  122. en:administration of drug or medicament via intraarterial route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via intraarterial route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  123. en:administration of drug or medicament via intrapleural route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via intrapleural route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  124. en:administration of drug or medicament via ophthalmic route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via ophthalmic route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  125. en:administration of drug or medicament via otic route --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of drug or medicament via otic route | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  126. en:administration of hormone (procedure) --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of hormone (procedure) | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  127. en:administration of muscle relaxant --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of muscle relaxant | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  128. en:administration of prescribed medications and solutions --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of prescribed medications and solutions | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  129. en:administration of radiopharmaceutical --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of radiopharmaceutical | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  130. en:administration of sulfonylurea --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration of sulfonylurea | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  131. en:administration, intranasal --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration, intranasal | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  132. en:administration, intravaginal --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration, intravaginal | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  133. en:administration, oral --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:administration, oral | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  134. en:anesthesia procedure --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:anesthesia procedure | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  135. en:continuous infusion of therapeutic substance --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:continuous infusion of therapeutic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  136. en:diagnostic dye introduction --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:diagnostic dye introduction | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  137. en:epidural block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:epidural block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  138. en:giving aperient --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:giving aperient | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  139. en:immunization --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:immunization | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  140. en:infusion of steroid --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:infusion of steroid | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  141. en:inhalation drug administration --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:inhalation drug administration | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  142. en:injection into bursa --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection into bursa | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  143. en:injection of anesthetic agent into pudendal nerve --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of anesthetic agent into pudendal nerve | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  144. en:injection of collagen --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of collagen | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  145. en:injection of depot antipsychotic agent --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of depot antipsychotic agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  146. en:injection of drug or medicament into macula --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of drug or medicament into macula | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  147. en:injection of sclerosing agent --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of sclerosing agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  148. en:injection of spinal saline --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of spinal saline | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  149. en:injection of streptokinase --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of streptokinase | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  150. en:injection of strontium-89 --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of strontium-89 | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  151. en:injection of therapeutic substance around sympathetic nerve --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance around sympathetic nerve | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  152. en:injection of therapeutic substance around the eye --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance around the eye | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  153. en:injection of therapeutic substance into bladder wall --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance into bladder wall | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  154. en:injection of therapeutic substance into heart --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance into heart | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  155. en:injection of therapeutic substance into penis --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance into penis | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  156. en:injection of therapeutic substance into salivary gland --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of therapeutic substance into salivary gland | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  157. en:injection of thrombin using ultrasound guidance --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of thrombin using ultrasound guidance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  158. en:injection of thrombolytic agent direct into coronary artery --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of thrombolytic agent direct into coronary artery | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  159. en:injection of urokinase --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:injection of urokinase | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  160. en:intermittent infusion of therapeutic substance --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:intermittent infusion of therapeutic substance | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  161. en:intravenous fluid replacement --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:intravenous fluid replacement | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  162. en:introduction of therapeutic substance into ligament of joint --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:introduction of therapeutic substance into ligament of joint | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  163. en:introduction of therapeutic substance into vein --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:introduction of therapeutic substance into vein | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  164. en:iontophoresis administration of treatment --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:iontophoresis administration of treatment | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  165. en:local anesthetic popliteal fossa block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:local anesthetic popliteal fossa block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  166. en:lumbar plexus block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:lumbar plexus block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  167. en:manual reduction of closed dislocation of shoulder joint under anesthesia --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:manual reduction of closed dislocation of shoulder joint under anesthesia | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  168. en:medical procedure --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medical procedure | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  169. en:medication administration during home visit --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medication administration during home visit | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  170. en:medication administration: intradermal --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medication administration: intradermal | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  171. en:medication administration: intramuscular --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medication administration: intramuscular | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  172. en:medication administration: intravenous --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medication administration: intravenous | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  173. en:medication administration: subcutaneous --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:medication administration: subcutaneous | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  174. en:neural block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:neural block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  175. en:pharmacotherapy --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:pharmacotherapy | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  176. en:reduction of symphysis pubis dislocation with anesthesia and with manipulation --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:reduction of symphysis pubis dislocation with anesthesia and with manipulation | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  177. en:retrobulbar injection of anesthetic agent --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:retrobulbar injection of anesthetic agent | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  178. en:sedation --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:sedation | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  179. en:self administration --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:self administration | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  180. en:special administration of medication --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:special administration of medication | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  181. en:sphenopalatine ganglion block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:sphenopalatine ganglion block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  182. en:spinal block --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:spinal block | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  183. en:subcutaneous drug therapy --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:subcutaneous drug therapy | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  184. en:trabeculectomy with intraoperative application of antimetabolite --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:trabeculectomy with intraoperative application of antimetabolite | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  185. en:transfusion antithrombin iii factor --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:transfusion antithrombin iii factor | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  186. en:transfusion of cryoprecipitate --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:transfusion of cryoprecipitate | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  187. en:transfusion of pentastarch --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=en:transfusion of pentastarch | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  188. injection --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=injection | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  189. perfusion --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=perfusion | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  190. procédure médicale --- r_associated #0: 20 --> en:administration of heavy metal antagonist
    n1=procédure médicale | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=20
  191. Procédure médicale --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=Procédure médicale | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  192. en:medicament --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=en:medicament | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  193. en:medicinal product --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=en:medicinal product | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  194. en:tablet --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=en:tablet | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  195. intervention anesthésique --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=intervention anesthésique | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  196. medicament --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=medicament | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  197. médicament --- r_associated #0: 15 --> en:administration of heavy metal antagonist
    n1=médicament | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=15
  198. Médicament --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=Médicament | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  199. acte médical --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=acte médical | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  200. administration d'agent anti-infectueux --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=administration d'agent anti-infectueux | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  201. anæsthésie --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=anæsthésie | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  202. en:medicine --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=en:medicine | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  203. en:pill --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=en:pill | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  204. médicaments --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=médicaments | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  205. perfusion d'agent anti-infectueux --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=perfusion d'agent anti-infectueux | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  206. pharmacothérapie --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=pharmacothérapie | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  207. procédure d'anesthésie --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=procédure d'anesthésie | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  208. rachi-anesthésie --- r_associated #0: 10 --> en:administration of heavy metal antagonist
    n1=rachi-anesthésie | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=10
  209. administration de médicaments prescrits basée sur les résultats des gaz du sang artériel --- r_associated #0: 5 --> en:administration of heavy metal antagonist
    n1=administration de médicaments prescrits basée sur les résultats des gaz du sang artériel | n2=en:administration of heavy metal antagonist | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr